| Disease | Chest roentgenographic features | Reference | Chemotherapeutic agents | Reference |
| Malaria | Diffuse interstitial pulmonary edema, pleural effusion, lobar consolidation, bilaterally pulmonary infiltrates, diffuse bilateral alveolar opacities, bilateral basal ground glass opacities | [12–15] | Chloroquine (all Plasmodium species), Artemisinin-based combination regimens (all Plasmodium species) | [1, 11, 20, 22–25] |
| Amoebiasis | Pleural effusion, basal pulmonary involvement, elevation of hemidiaphragm | [1] | Metronidazole, diloxanide, lactoferrin, lactoferricin | [34, 35] |
| Leishmaniasis | Pleural effusion, mediastinal lymphadenopathy, pneumonitis (immunocompromised status) | [39, 40] | Pentavalent antimonials, pentamidine, amphotericin B, miltefosine | [48] |
| Trypanosomiasis | Pulmonary alveolar hemorrhage, alveolitis, pneumonitis, pulmonary emphysema (in vivo) | [52, 54] | Eflornithine, melasoprol (in vivo) | [8, 56, 57] |
| Pulmonary larval migrans | Localized patchy infiltrates | [1] | Diethylcarbamazine, Mebendazole, Albendazole | [67–69] |
| Toxoplasmosis | Interstitial pneumonia, diffuse alveolar damage, necrotizing pneumonia, obstructive or lobar pneumonia | [71, 72] | Combination regimen of pyrimethamine and sulfadiazine | [1] |
| Babesiosis | Noncardiogenic diffuse-bilateral-interstitial pulmonary edema and adult respiratory distress syndrome (complicated case) | [78] | Combination of clindamycin and quinine, or atovaquone and Azithromycin | [79, 80] |
| Filariasis | Bilateral military infiltrates, prominent hila with increased lung markings, normal | [84–89] | Diethylcarbamazine | [101–106] |
| Dirofilariasis | A solitary-coin or multiple nodules (usually less than 3 cm. in size, usually in the periphery of the right lower lobe) | [1, 109, 113, 114, 117, 118] | No specific medical therapy, but ivermectin may be useful, usually curative by wedge resection of the pulmonary nodule | [126, 127] |
| Strongyloidiasis | Bronchopneumonia, alveolar hemorrhages | [1] | Thiabendazole | [135] |
| Ascariasis | Peripherally basal opacities, unilateral or bilateral transient-migratory-non-segmental opacities of various sizes | [142] | Mebendazole, albendazole, pyrantel pamoate, piperazine citrate, ivermectin | [1] |
| Ancylostomiasis | Bronchitis, bronchopneumonia, transient pulmonary infiltrates |
[128, 143, 144] | Mebedazole, albendazole, pyrantel pamoate, ivermectin | [128] |
| Paragonimiasis | Patchy consolidation, pleural thickening, pleural effusion, nodular lesions, cystic lesions, cavities, normal | [150, 153, 155–158] | Praziquantel, triclabendazole, niclofolan, bithionol | [147, 150, 164, 165] |
| Schistosomiasis | Multiple ill-defined small nodular lesions with ground glass-opacity halo, prominent hila, increased lung markings, enlargement of the right ventricle, dilatation of the pulmonary arteries and trunk as well as their interlobar branches (pulmonary hypertension and cor pulmonale) | [166, 170–173, 176] | Praziquantel, artemisinin derivatives | [166]
|
| Hydatidosis/echinococcosis | Solitary or multiple round opacities with air-fluid level, water-lily sign, onion-peel sign, crescent sign | [1, 184] | Praziquantel, mebendazole, albendazole, | [187] |
| Trichinellosis | Patchy infiltrates, exaggerated and fuzzy lung markings, hilar enlargement | [192, 194, 195] | Mebendazole, albendazole | [128, 192] |
|
|